Efficiency of Electrical Cardioversion of Paroxysmal Atrial Fibrillation in the Use of Bipolar QuasiSinusoidal Impulse in Patients with Coronary Heart Disease

Objective: to study the dose-dependent efficacy of bipolar quasisinusoidal (BPQS) impulse in eliminating 24—48-hour atrial  fibrillation  (AF)  in  patients  with  different  clinical  forms  and  course  of  coronary  heart  disease  (CHD)  and  different transthoracic  resistance  (TTR). Subjects ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obshchai͡a︡ reanimatologii͡a 2014-06, Vol.10 (2), p.41-49
Hauptverfasser: Vostrikov, V. A., Razumov, K. V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: to study the dose-dependent efficacy of bipolar quasisinusoidal (BPQS) impulse in eliminating 24—48-hour atrial  fibrillation  (AF)  in  patients  with  different  clinical  forms  and  course  of  coronary  heart  disease  (CHD)  and  different transthoracic  resistance  (TTR). Subjects  and  method.  Ninety-seven  patients  (103  AF  episodes)  who  had  undergone transthoracic electrical cardioversion (ECV) with a BPQS impulse according to the protocol of dose escalation (from 1—2 to 5 discharges) were analyzed. The discharge power range was from ≤40—65 to 195 J. The diameter of electrodes was 12 cm; its location was anterolateral. Results. Elimination of 70% of the AF episodes required 1—2 discharges; that of 18.3 and 11.7% of the episodes needed 3 and 4—5 discharges, respectively. Low-power (40—85 J) discharges were found to be highly effective (90%) in eliminating 24-hour AF; ~90% ECV success was recorded in patients with 28—48-hour episodes when greater power (≤115 J) discharges were applied to 17% of the patients. The total success rate for cardioversion was 94.2%; that of emergency ECV was 81% (p=0.022). The ECV success rate was 88.6% in patients with clinically relevant and severe (acute chronic) heart failure (HF), 98% in those with mild HF and without its clinical signs (p
ISSN:1813-9779
2411-7110
DOI:10.15360/1813-9779-2014-2-41-49